HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A trial of emepronium bromide for the treatment of urinary incontinence in the elderly mentally ill.

Abstract
A double-blind controlled trial was conducted of emepronium bromide against placebo in elderly mentally ill patients in hospital with urinary incontinence. No significant difference was found between 200 mg emepronium bromide 3-times daily and placebo in treating day-time or nocturnal urinary incontinence for patients suffering from chronic organic brain syndrome or from chronic functional psychiatric illness.
AuthorsA J Williams, J K Prematalake, R L Palmer
JournalPharmatherapeutica (Pharmatherapeutica) Vol. 2 Issue 8 Pg. 539-42 ( 1981) ISSN: 0308-051X [Print] England
PMID7019932 (Publication Type: Clinical Trial, Controlled Clinical Trial, Journal Article)
Chemical References
  • Quaternary Ammonium Compounds
  • Emepronium
Topics
  • Aged
  • Clinical Trials as Topic
  • Dementia (complications)
  • Emepronium (therapeutic use)
  • Female
  • Humans
  • Male
  • Neurocognitive Disorders (complications)
  • Quaternary Ammonium Compounds (therapeutic use)
  • Urinary Incontinence (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: